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ABSTRACT 
 
Background: Recent guidelines from the United Kingdom recommend that men and 
women should drink no more than 14 units of alcohol per week. This recommendation takes 
into account the link between alcohol and several cancers; however, there is a dearth of 
high quality evidence from the UK to support this. 
 
Methods: Alcohol consumption using a detailed diary was obtained from 8,670 adults 
representative of the UK population in 1984/5, with follow-up data from cancer registries 
until 2009. Hazard ratios (HR) adjusted for several variables including cigarette smoking 
were calculated for cancers of the breast, lung, colorectum and prostate separately using 
Cox regression. 
 
Results: Units per week on a typical basis, fitted as a linear term, was associated with 
breast cancer in women (HR=1.27 per 10 units/week; 95% CI 1.03-1.58) and lung cancer 
in men (HR=1.16; 1.06-1.27). Increased risks of lung (HR=2.23; 1.18-4.24) and colorectal 
(HR = 2.28; 1.13-4.57) cancer were seen in men at 15-28 units/week along with higher 
levels of consumption. Some findings differed by alcohol type.  
 
Conclusions:  Overall, alcohol consumption of 15-28 units/week may be harmful in men 
with respect to common cancers. A linear association between alcohol consumption and risk 
of breast cancer was observed in women. 
 
 
  
3 
 
 
INTRODUCTION 
 
In January 2016, the United Kingdom’s (UK) Chief Medical Officer advised that men should 
consume 14 units of alcohol per week or less, reduced from 21 units, in line with women. 
These guidelines were influenced in part by evidence that the risk of a number of cancers 
increases from any level of regular drinking, and that the risk of dying from alcohol is less 
than 1% when consumption is kept below 14 units per week.(1)  
 
The majority of the evidence that influenced updates to the alcohol guidelines was from 
outside of the UK. Also, a previous report from the International Agency for Research on 
Cancer (IARC) indicated there might be genetic differences in alcohol metabolism which 
could indicate the possibility of geographical variations in the relationship between alcohol 
and cancer.(2) Most studies concur that alcohol is a risk factor for cancers of the oral cavity, 
pharynx, larynx, oesophagus, liver and colorectum, and alcohol is listed as a carcinogen for 
these sites by IARC.(2) However, over half of the cancers diagnosed in the UK are of the 
breast, lung, prostate or colorectum, and so it is these cancers that pose the largest burden 
on society.(3) The evidence as to whether alcohol affects incidence of lung cancer is 
conflicting (4-8). For prostate cancer, the evidence is also unclear,(9, 10) with Bagnardi et 
al reporting raised risks at low and moderate consumption in a recent meta-analysis.(4) 
Although alcohol is classed as a carcinogen for colorectal cancer, one UK study found no 
association,(11) whilst others were conducted only in one gender(8, 12) or only assessed a 
high level of consumption.(13) A previous meta-analysis has established a link between 
alcohol and breast cancer,(4) although whether there is a level of alcohol consumption that 
can be considered to be safe is still a debated topic, and data from the UK are sparse. 
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This study aimed to establish the long term risk of developing one of the four most common 
cancers based on self-reported alcohol consumption from a sample representative of the UK 
adult population with a follow-up of 25 years.   
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METHODS 
Data source and participants 
The Health and Lifestyle Survey (HALS1) was conducted in 1984/5 to describe the health 
beliefs, attitudes and behaviours of a representative sample of the population of England, 
Wales and Scotland, and how these related to physiological measurements of health.(14)  
The survey randomly sampled 9,003 people aged 18 or over from England, Wales and 
Scotland. Stages of the survey included an hour-long structured interview and a nurse visit 
to record physiological measures and cognitive function. Full details of the survey have been 
reported elsewhere.(15) In 1991/2 a follow-up survey (HALS2) was conducted where 
equivalent information was collected from 5,290 people who took part in the original 
survey. 
Exposure measures 
During the interview participants were asked to complete an alcohol diary for the week prior 
to interview, if they had consumed at least one alcoholic drink in the preceding seven days. 
Participants were asked to state the type of drink and quantity in pub measures which was 
in the form of pints (568 millilitres, ml), glasses (typically 175 ml) and measures (typically 
25 ml) for beer, wine and spirits respectively. Participants were asked whether the 
consumption declared in the diary was ‘typical'’ of their normal consumption (coded as “less 
than usual”, “usual/typical” or “more than usual”). Using these diaries, two exposure 
measures were created: a continuous variable for units consumed per week and a 
categorical variable for the number of units consumed per week ( ‘0’, ‘1-14’ ’15-28’ and 
‘>28’ units/week based on the revised UK alcohol guidelines).These variables were created 
both for total alcohol consumption and for each type of alcoholic drink. Self-report alcohol 
measures have been shown to be both valid and reliable by various studies and 
retrospective drink diaries have frequently been cited as being more accurate than quantity-
frequency methods.(16-18) 
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Outcome measures 
Cancer data in the UK are collated using the comprehensive reporting systems of the 
National Cancer Registration Schemes in England, Wales, Scotland and Northern Ireland. 
This information is sent to the Office of National Statistics (ONS), and was available until 
June 2009.(19) From these cancer records six outcome variables were created: breast 
cancer in women, prostate cancer in men, as well as lung cancer and colorectal cancer for 
both men and women.  
Covariates 
Relevant covariates used in the analysis were identified from previous studies.(13, 20, 21) 
Variables included in the model regardless of significance were ethnicity, income (12 
categories), self-reported health, smoking status (ex-smoker, non-smoker, <20 a day, ≥ 20 
a day), body mass index (BMI) and exercise. We assessed exercise on the basis of the 
question “Overall do you think you get enough exercise?” (“yes”, “no” or “don’t know”). 
Other covariates considered were age at baseline, family history of cancer, job type (non-
manual, manual or other), diet and vitamin supplement taking. As none of these variables 
changed the hazard ratio by more than 10% in any of the reported analyses, they were not 
included in the adjusted models.  
 
For each covariate that contained less than 1% missing data, the missing values were set to 
the mode (ethnicity, self-reported health, smoking status and exercise), thus ensuring all 
participants were included in the analysis. BMI was missing for 18.8% of participants; 
therefore a separate category was created containing missing values to preserve the overall 
sample size. Income was missing for 20.1% of participants; as this was fitted as a linear 
term, the sample size was preserved by also fitting a separate binary variable indicating if 
the respondent had missing income data.  
Statistical Analyses 
Cox proportional hazards regression was used to analyse the association between the 
alcohol exposures and the incidence of breast, lung, prostate and colorectal cancer in men 
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and women individually, with the person’s age rather than time from the HALS 1 survey as 
the time component. The follow-up period started on the date of the HALS1 survey and 
ended at the date of cancer under investigation, date of death or June 2009; whichever was 
earliest. Alcohol consumption was examined in relation to each of the six outcomes 
separately. This meant only people who had the cancer of interest prior to the start of 
follow-up were excluded from each analysis; therefore the number of participants in each 
analysis varied. 
 
The primary analysis was conducted using all participants from HALS1 who declared their 
previous week’s alcohol consumption to be “typical” (analysis 1 in table 2). A secondary 
analysis was performed using all participants, but with their exposure measure adjusted if 
they reported their consumption in the week of the diary was “atypical” (analysis 2 in table 
2). Those who reported their alcohol consumption was ‘more than usual’ were moved down 
a category (e.g. from 15-28 units to 1-14 units), and those who reported ‘less than usual’ 
were moved up a category. To address concerns that such an adjustment would be more 
necessary for someone whose consumption was close to the threshold, we also presented 
results from an analysis where participants in the three drinking categories (>0 units) only 
changed category if their consumption was within 5 units of the threshold (i.e. someone 
would only be promoted into the 15-28 unit/week category if they consumed between 10 
and 14 units/week, analysis 3 presented in the supplementary material for online only 
publication). 
 
For analyses of individual type of alcohol, only those who completed HALS2 were included. 
This is because for these participants, the alcohol diaries from the HALS1 survey were re-
analysed retrospectively to calculate the number of units of each type of alcohol consumed 
of beer, wine and spirits separately in addition to a figure for the total units. Participants 
who did not take part in HALS2 did not had their diaries from HALS1 re-analysed in this 
way. All analysis was carried out using Stata version 14.  
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RESULTS 
Study participants 
The HALS1 sample comprised 9,003 participants, of whom 8,670 (3,763 men and 4,907 
women) contributed valid cancer follow-up data. Of these, 6,721 (2,780 men and 3,941 
women) declared their previous week alcohol consumption to be “typical” and contributed to 
the primary analysis. The total sample were an average of 45 years old, were 
predominantly (>96%) of white ethnicity and 70% rated their health as good or excellent 
(table 1). 
 
Cancer risk by total alcohol consumption 
For the categorical exposure measure, alcohol consumption at fewer than 14 units per week 
was not associated with increased cancer risk in any of the analyses (table 2). However, 
some increases in cancer risk were found at higher levels of consumption. Men who 
consumed over 14 units per week had an increased risk of lung cancer with adjusted HRs of 
2.23 (CI: 1.18-4.24) when consuming ‘15-28 units’ and 2.68 (CI: 1.42-5.07) when 
consuming ‘>28 units’.  There was also an increased risk of colorectal cancer in men as 
their consumption increased, however, once adjusted for covariates, this association was 
only statistically significant for ’15-28 units’ category in the secondary analysis (HR=2.28, 
CI: 1.13-4.57). There were no significantly raised risks for any specific categories of alcohol 
consumption in terms of lung, breast and colorectal cancer in women and for prostate 
cancer in men.  
 
For the continuous exposure measure, a statistically significant relationship was observed 
between total alcohol per 10 units per week and breast cancer (HR=1.27, CI: 1.03-1.58) 
and lung cancer in men (HR= 1.16, CI: 1.06-1.27). There was also a positive relationship 
between alcohol consumption and colorectal cancer in men, however, this did not reach 
statistical significance (HR=1.10; CI: 0.96-1.27). There was no evidence of a linear trend 
for any of the other three outcomes. 
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Cancer risk stratified by alcohol type (primary analysis only) 
Results for beer consumption and lung cancer in men were similar to total consumption with 
HRs of 3.08 and 4.25 (CI: 1.21-7.84 and 1.79-10.1) for the ’15-28’ and ‘>28’ units per 
week respectively, reflecting the fact that beer was the type of alcohol most often 
consumed (table 3). A similar trend was seen with beer and colorectal cancer in men. 
 
Small numbers of drinkers in the higher alcohol consumption categories (see table 1) meant 
that consistent patterns with respect to wine and spirit consumption were more difficult to 
discern. Among men for colorectal cancer, there was a suggestion of an increase in risk at 
moderate consumption levels (15-28 units) for spirits (HR=6.91; 95% CI 1.86-25.6) with 
evidence of a linear trend, and for wine even at low levels (1-14 units) (HR= 4.94, CIs: 
2.17-11.3). An association between wine consumption and lung cancer in women was also 
observed (HR= 19.9, CI: 1.93-206), however this is based on one cancer out of only three 
women who consumed alcohol at this level. The only statistically significant linear 
association was between consumption of spirits and breast cancer, with an HR of 2.06 per 
10 units (CI: 1.30-2.38). 
10 
 
DISCUSSION 
Main Finding of this Study 
We used data from a cohort of UK adults with 25 years of follow-up to explore whether 
recent changes to the UK alcohol guidelines are supported with respect to the risk of the 
most common cancers. Where associations with cancer were found, these occurred in men 
at moderate levels of consumption (15-28 units), supporting changes to reduce the 
recommended weekly intake in men to 14 units a week. Insufficient numbers of women 
drinking at high levels during the time of the initial survey meant we were unable to 
determine whether drinking at this level was associated with a similar degree of increased 
risk in women; however, an association between total alcohol consumption and breast 
cancer was found when alcohol was treated continuously. There was a suggestion that type 
of alcohol may be important, indicating an important area for future research.  
What is already known on the topic? 
Overall, our findings support the view of the IARC that alcohol consumption is linked to 
cancers of the breast and colorectum. (2) They also concur with findings from a meta-
analysis conducted by Bagnardi et al in 2015 which reported associations between alcohol 
consumption and lung and colorectal cancers in men, yet not women.(4) The previous 
meta-analysis along with a prominent paper by Cao et al (20) also supports our finding of a 
dose response relationship between alcohol and breast cancer. However, the latter paper 
found this effect from low consumption levels below 13 units per week, in contrast with our 
conclusion that there was no evidence of harm at low levels. A similar result was found in 
the UK million women study which observed a 13% higher risk of breast cancer among 
women who drank 7-14 units/week than those who drank ≤2 units/week (8), this equated 
to a similar effect size to that reported by Cao (20). The discrepancy between our results 
and those of these other cohorts could be due to smaller size of the present study. Whilst a 
13% increase in risk with 1-2 drinks/day would be considered to be a small effect size, from 
a population health perspective this could be significant given the large portion of the UK 
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population who consume alcohol at this level (40% of men and women in the HALS survey 
and 40% of the million women cohort who drank 3-14 units/week).  
 
What this study adds 
A key strength of our study is the relevance to UK public health at this time, just one year 
after new alcohol guidelines have been issued for the first time since 1995. Whilst data have 
been published on this topic from larger cohorts of individuals in recent years from Europe 
and the US,(8, 20, 22) participants from these were older on average at the time of 
recruitment or followed up for much shorter periods of time. Our study in contrast provides 
data on a population of both men and women most of whom are still alive and at an 
average age where they are likely to be making demands on the NHS currently. This makes 
the research appropriate to today’s population who may be affected by cancer. Also, by 
quantifying the effect alcohol has on the risk of the four most common cancers in the UK 
when consuming above and below the new recommended limits and by doing so separately 
for men and women from the same population we provide evidence to directly support the 
recent change in UK guidance. The four cancer types under investigation account for over 
50% of new cancer diagnoses in the UK, therefore in terms of the overall burden of cancer 
attributable to alcohol use these findings are of high relevance.  
 
Whilst alcohol is considered a carcinogen for colorectal cancer by IARC in men and women, 
we found some evidence of a raised risk when consuming ≥15 units/week in men but not in 
women. Rather than being caused by biological differences, this could be due to insufficient 
numbers of women drinking at high levels to establish an effect.  For instance, we reported 
only 3,325 person-years of follow-up in women (2 cancers) consuming ≥15 units per week 
compared with 16,709 person-years of follow-up in men (18 cancers). However, in a larger 
study by Allen et al.(8) comprising women only, no association was found for colon cancer 
whilst a modest 25% increase was seen when consuming ≥15 units/week for rectal cancer 
providing further indication of a possible gender difference for this cancer type.  
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Limitations of this study 
The main limitation of this study is the lack of statistical power for some analyses due to a 
relatively small cohort size especially when alcohol levels were categorised. In particular, 
the small numbers of women in higher alcohol consumption categories meant that we were 
unable to assess the risk of cancer in women who consumed high levels of alcohol due to 
insufficient events. An analysis presented in the recent guideline update reported a 16% 
increase in risk of breast cancer at 14 units of alcohol per week and 40% at 35 units.(1) 
Our study sample had insufficient statistical power to detect differences of this size. 
However, with the continuous exposure measure, we observed a 27% increase in breast 
cancer risk per 10 units/week, an effect size which was larger than the 10% increase in 
breast cancer per 10 units/week in an earlier meta-analysis of 53 studies.(23) Another 
consequence of the lack of statistical power was our inability to assess the risk in people 
consuming 15 to 21 units. This is the group who among men consumed alcohol quantities 
under the old recommended upper limit, yet over the new one.  
 
Another limitation is that our results for lung cancer are liable to be influenced by residual 
confounding by smoking as we were only able to consider cigarette smoking in 4 categories 
rather than quantifying actual cigarette consumption. The potential for residual confounding 
could account for why a meta-analysis on this topic found no association between alcohol 
and lung cancer when confined to never smokers.(24) Third, alcohol was only assessed at 
one time point (1984/5) so these may not represent alcohol levels 20-years later at the 
time when many of our cohort were still at risk of cancer. However, as we are primarily 
interested in how someone’s alcohol drinking influences their health longer term rather than 
the risk immediately following a change in alcohol consumption this would not be considered 
a major concern. Finally, there is a recognised problem in alcohol research of mixing 
abstainers and former drinkers in studies of alcohol consumption. This is problematic given 
that many of the latter group could contain people who gave up drinking due to ill health. 
However, we anticipate that only a small portion of our non-drinkers would come into this 
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category as our study population were younger on average than those in previous studies. 
Furthermore, adjustment for self-reported health in our regression analysis would have 
removed much of the resulting confounding.  
 
Conclusion 
We found that alcohol consumption between 15-28 units per week was associated with an 
increased risk of lung and colorectal cancers in men, thus supporting recent changes to the 
UK alcohol guidelines. Before the next guideline update, more data are needed evaluating 
the risk of cancer in women who consume high levels of alcohol to enable us to state with 
confidence whether it is appropriate for recommended intakes to be the same in men and 
women. We also highlighted some potentially important differences based on alcohol type. 
Whilst this would suggest the need for future studies to stratify by alcohol type, it must also 
be recognised that future public health messages would be more challenging to convey if it 
was to be established that cancer risks were notably influenced by the type of alcohol 
consumed. 
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Table 1: Comparison of baseline characteristics between analytical populations 
 
Characteristic HALS1 initial participants 
(n=9,003) 
Analytical sample 1 
(n=6,721 ) 
Analytical sample 2 
(n=8,670) 
Men (n=3,905) Women (n=5,098) Men (n=2,780) Women (n=3,941) Men (n=3,763) Women (n=4,907) 
Age Mean (SD) 45.57 (17.61) 46.08 (17.81) 47.90 (17.90) 48.00 (18.02) 45.75 (17.65) 46.33 (17.78) 
Ethnicity White 96.59% 96.96% 96.22% 96.90% 96.76% 97.25% 
Non-white 3.41% 3.04% 3.78% 3.10% 3.24% 2.75% 
Self-reported health Excellent 21.59% 19.75% 21.40% 19.18% 21.61% 19.69% 
Good 50.09% 51.77% 49.03% 51.13% 50.01% 51.70% 
Fair 23.30% 22.87% 24.32% 23.70% 23.39% 22.97% 
Poor 5.02% 5.61% 5.25% 5.99% 5.00% 5.64% 
Smoking status Non 33.67% 49.08% 31.62% 49.96% 33.62% 48.89% 
Ex 31.81% 19.65% 33.85% 19.31% 32.02% 19.85% 
<20 a day 17.26% 19.64% 17.01% 19.31% 17.17% 19.50% 
>20 a day 17.26% 11.63% 17.52% 11.42% 17.19% 11.76% 
BMI Mean (SD) 24.80 (3.68) 24.33 (4.39) 24.83 (3.69) 24.41 (4.49) 24.81 (3.70) 24.36 (4.39) 
Exercise Enough 54.57% 52.59% 56.62% 54.88% 54.77% 52.91% 
Not Enough 45.43% 47.41% 43.38% 45.12% 45.23% 47.09% 
Total number of 
units consumed 
 
Median (IQR) 7 (0-20) 0 (0-5) 6 (0-18) 0 (0-3) 7 (0-20) 0 (0-5) 
0 29.52% 52.47% 35.22% 
 
60.29% 29.43% 52.52% 
1-14 37.03% 41.94% 34.71% 35.65% 37.06% 41.96% 
15-28 16.81% 4.85% 15.22% 3.40% 16.78% 4.77% 
>28 16.63% 0.75% 14.86% 0.66% 16.42% 0.75% 
Units of beer 
consumed 
Median (IQR) 4 (0-17) 0 (0-0) 2 (0-16) 0 (0-0) 4 (0-17) 0 (0-0) 
0 38.41% 80.73% 43.59% 83.26% 38.43% 80.79% 
1-14 33.84% 17.67% 30.82% 15.43% 33.64% 17.62% 
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15-28 14.48% 1.38% 12.89% 1.14% 14.60% 1.36% 
>28 13.27% 0.23% 12.71% 0.17% 13.32% 0.23% 
        
Units of wine 
consumed 
Median (IQR) 0 (0-0) 0 (0-2) 0 (0-0) 0 (0-1) 0 (0-0) 0 (0-2) 
0 76.38% 67.85% 79.94% 74.10% 76.34% 67.92% 
1-14 22.44% 30.58% 19.09% 24.73% 22.47% 30.52% 
15-28 1.00% 1.47% 0.79% 1.05% 1.01% 1.46% 
>28 0.17% 0.10% 0.18% 0.13% 0.18% 0.10% 
Units of spirits 
consumed 
Median (IQR) 0 (0-0) 0 (0-0) 0 (0-0) 0 (0-0) 0 (0-0) 0 (0-0) 
0 76.99% 78.76% 80.67% 83.26% 76.91% 78.83% 
1-14 21.01% 20.32% 17.39% 16.06% 21.06% 20.24% 
15-28 1.48% 0.92% 1.40% 0.67% 1.50% 0.93% 
>28 0.52% 0.00% 0.55% 0.00% 0.53% 0.00% 
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Table 2: Cancer risk by category of alcohol consumption (total consumption) 
 
 Analysis 1 – Typical alcohol consumers only (n=6,721) Analysis 2 – Analysis with imputed alcohol categories (n=8,670) 
 Events Person-years Incidence/ 
1000 p-ys 
Crude hazard ratio 
(95% CI) 
Adjusted hazard ratio* 
(95% CI) 
Events Person-years Incidence/ 
1000 p-ys 
Crude hazard ratio 
(95% CI) 
Adjusted hazard 
ratio* (95% CI) 
Breast cancer           
0 90 43,977 2.0 1.00 1.00 105 54,465 1.9 1.00 1.00 
1-14 49 28,588 1.7 0.93 (0.65-1.32) 0.91 (0.63-1.30) 59 34,792 1.7 0.97 (0.71-1.34) 0.95 (0.69-1.32) 
15-28 9 2,667 3.4 1.86 (0.94-3.69) 1.80 (0.89-3.63) 16 6,674 2.4 1.57 (0.92-2.67) 1.47 (0.86-2.52) 
>28 2 557 3.6 2.32 (0.57-9.46) 2.22 (0.53-9.20) 2 825 2.4 1.79 (0.44-7.28) 1.86 (0.42-7.13) 
Continuous (10 units/week)   1.27  (1.03-1.56) 1.27 (1.03 – 1.58)      
Lung cancer (men)         
0 23 16,827 1.4 1.00 1.00 25 22,235 1.1 1.00 1.00 
1-14 20 17,821 1.1 0.85 (0.47-1.55) 0.93  (0.50-1.69) 28 23.564 1.2 1.09 (0.63-1.87) 1.19 (0.69-2.05) 
15-28 17 8,519 2.0 2.26 (1.20-4.24) 2.23 (1.18-4.24) 22 16,004 1.4 2.08 (1.17-3.69) 2.09 (1.16-3.75) 
>28 20 8,154 2.5 3.16  (1.71-5.81) 2.68 (1.42-5.07) 21 10,205 2.1 3.36 (1.87-6.06) 2.91 (1.58-5.34) 
Continuous (10 units/week)  1.21  (1.11-1.32) 1.16 (1.06-1.27)      
Lung cancer (women)          
0 42 44,729 0.9 1.00 1.00 43 55,340 0.8 1.00 1.00 
1-14 26 29,049 0.9 1.29 (0.79-2.12) 1.21 (0.72-2.03) 27 35,351 0.8 1.32 (0.81-2.15) 1.26 (0.77-2.08) 
15-28 0 2,784 0.0 NE NE 0 6,809 0.0 NE NE 
>28 1 577 1.7 2.91 (0.40-21.2) 1.72 (0.23-12.9) 1 845 1.2 2.87 (0.40-21.0) 1.64 (0.22-12.2) 
Continuous (10 units/week)  1.07  (0.69-1.67) 0.84  (0.52-1.34)      
Colorectal cancer (men)          
0 14 16,860 0.8 1.00 1.00 17 22,268 0.8 1.00 1.00 
1-14 24 17,853 1.3 1.73 (0.90-3.36) 1.68 (0.86-3.28) 28 23,599 1.2 1.64 (0.89-2.99) 1.58 (0.86-2.91) 
15-28 10 8,539 1.2 2.34 (1.04-5.29) 2.26 (0.99-5.17) 16 16,025 1.0 2.41 (1.21-4.80) 2.28 (1.13-4.57) 
>28 8 8,170 1.0 2.54 (1.04-6.10) 2.22 (0.89-5.53) 8 10,221 0.8 2.21 (0.94-5.19)  2.01 (0.84-4.82) 
Continuous (10 units/week)  1.12 (0.98-1.28) 1.10 (0.96-1.27)      
Colorectal cancer (women)         
0 38 44,813 0.8 1.00 1.00 42 55,424 0.8 1.00 1.00 
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1-14 21 29,077 0.7 1.31 (0.77-2.25) 1.20 (0.69-2.12) 24 35,388 0.7 1.34 (0.81-2.22) 0.82 (0.56-1.19) 
15-28 2 2,748 0.7 1.28 (0.31-5.31) 1.22 (0.29-514) 4 6,809 0.6 1.52 (0.54-4.25) 1.23 (0.73-2.06) 
>28 0 577 0.0 NE NE 0 855 0.0 NE NE 
Continuous (10 units/week) 1.07  (0.65-1.77) 0.98  (0.65-1.77)      
Prostate cancer          
0 34 16,712 2.0 1.00 1.00 43 22,075 1.9 1.00 1.00 
1-14 33 17,222 1.9 0.94 (0.58-1.52) 0.86 (0.53-1.41) 24 23,432 1.8 0.94 (0.61-1.43) 0.85 (0.55-1.30) 
15-28 12 848 1.4 1.14 (0.59-2.20) 1.04 (0.53-2.04) 19 15,917 1.2 1.09 (0.63-1.87) 0.99 (0.57-1.71) 
>28 5 812 0.6 0.58 (0.22-1.50) 0.51 (0.20-1.34) 6 10,712 0.6 0.58 (0.24-1.37) 0.51 (0.22-1.23) 
Continuous (10 units/week)  0.92  (0.78-1.09) 0.91  (0.76-1.07)      
NE Not estimable, CI confidence interval 
* Adjusted for ethnicity (white/non-white), income, self-rated health (excellent/good/fair/poor), smoking status (4 categories), body mass index (underweight/normal/overweight/obese/severely 
obese/unknown), exercise (self-rated, enough vs. not enough) 
As age of the participant was the unit of time in the above survival analysis (with age at the time of the HALS 1 survey the value at start of follow-up) the crude hazard ratios presented above are 
intrinsically adjusted for age. For this reason division of the raw incidence rates in the above table by the incidence rate in the reference group will often give very different values to the crude HR.   
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Table 3: Cancer risk by category of alcohol consumption (stratification by alcohol type): Typical consumption only 
 
 Beers Wines Spirits 
 Events Crude hazard ratio 
(95% CI) 
Adjusted hazard ratio* 
(95% CI) 
Events Crude hazard ratio 
(95% CI) 
Adjusted hazard ratio* 
(95% CI) 
Events Crude hazard ratio 
(95% CI) 
Adjusted hazard ratio* 
(95% CI) 
Breast cancer        
0 101 1.00 1.00 79 1.00 1.00 91  1.00 1.00 
1-14 11 0.67 (0.36-1.26) 0.66 (0.35-1.30) 32 1.20 (0.79-1.82) 1.18 (0.77-1.82) 20 1.14 (0.70-1.85) 1.12 (0.69-1.84) 
15-28 1 0.82 (0.11-5.91) 0.85 (0.12-6.21) 2 1.99 (0.49-8.10) 1.97 (0.48-8.17) 2   2.52 (0.62-10.2) 2.26 (0.55-9.30) 
>28 0 NE NE 0 NE NE 0 NE NE 
per 10 units/week 0.61  (0.24-1.55) 0.60  (0.23-1.53)  1.40  (0.87-2.24) 1.38  (0.84-2.26)  2.14  (1.35-3.38) 2.06  (1.30-3.28) 
Lung cancer (men)        
0 12 1.00 1.00 39 1.00 1.00 35 1.00 1.00 
1-14 13 1.85 (0.84-4.06) 1.80 (0.81-3.97) 6 0.56 (0.24-1.33) 0.94 (0.38-2.35) 9 1.00 (0.48-2.08) 1.25 (0.58-2.70) 
15-28 8 3.87 (1.57-9.56) 3.08 (1.21-7.84) 0 NE NE 1 1.39 (0.19-10.2) 1.80 (0.89-3.63) 
>28 12 6.93 (3.02-15.9) 4.25 (1.79-10.1) 0 NE NE 0 NE NE 
per 10 units/week 1.29  (1.15-1.44) 1.18  (1.03-1.33)  0.49  (0.11-2.20) 1.03 (0.28-3.71)  1.00  (0.59-1.72) 1.14  (0.66-1.96) 
Lung cancer (women)        
0 38 1.00 1.00 37 1.00 1.00 37 1.00 1.00 
1-14 6 1.35 (0.57-3.23) 1.30 (0.54-3.14) 6 0.59 (0.25-1.40) 0.75 (0.30-1.85) 7 1.04 (0.46-2.34) 0.91 (0.40-2.08) 
15-28 0 NE NE 0 NE NE 0 NE NE 
>28 0 NE NE 1 10.6 (1.45-77.5) 19.9 (1.93-206) 0 NE NE 
per 10 units/week 1.32  (0.57-3.09) 0.92 (0.36-2.31)  1.12  (0.46-2.68) 1.37 (0.55-3.42)  0.53  (0.10-3.00) 0.40  (0.06-2.42) 
Colorectal cancer (men)        
0 14 1.00 1.00 17 1.00 1.00 21 1.00 1.00 
1-14 11 1.46 (0.66-3.22) 1.21 (0.54-2.71) 15 3.21 (1.59-6.42) 4.94 (2.17-11.3) 7 1.30 (0.55-3.07) 1.30 (0.54-3.15) 
15-28 3 1.50 (0.43-5.26) 1.37 (0.38-4.94) 0 NE NE 3 8.69 (2.55-29.5) 6.91 (1.86-25.6) 
>28 2 3.38 (1.05-10.9) 2.91 (0.82-10.3) 0 NE NE 1 5.30 (0.71-39.8) 3.27 (0.38-28.4) 
10 units/week 1.09  (0.86-1.37) 1.05  (0.81-1.35)  1.92  (0.84-4.41) 2.05  (0.85-4.96)  1.38  (1.04-1.83) 1.26  (0.92-1.74) 
Colorectal cancer (women)        
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0 26 1.00 1.00 20 1.00 1.00 24 1.00 1.00 
1-14 2 0.82 (0.19-3.50) 0.76 (0.18-3.23) 7 1.46 (0.61-3.49) 1.29 (0.52-3.22) 4 0.99 (0.34-2.85) 0.90 (0.30-2.72) 
15-28 0 NE NE 1 5.28 (0.70-39.7) 5.93 (0.70-50.1) 0 NE NE 
>28 0 NE NE 0 NE NE 0 NE NE 
10 units/week 0.09 (<0.01-26.74) 0.08  (<0.01-29.87)  1.32  (0.50-3.52) 1.17  (0.40-3.46)  0.56  (0.07-4.39) 0.49  (0.06-4.38) 
Prostate cancer        
0 33 1.00 1.00 49 1.00 1.00 47 1.00 1.00 
1-14 24 1.26 (0.74-2.13) 1.25 (0.73-2.13) 14 1.06 (0.58-1.92) 1.02 (0.53-1.95) 15 1.23 (0.69-2.19) 1.13 (0.62-1.30) 
15-28 4 0.71 (0.25-2.01) 0.73 (0.25-2.08) 1 2.21 (0.30-16.1) 1.96 (0.24-15.7) 2 2.18 (0.53-8.99) 2.09 (0.49-8.87) 
>28 3 0.69 (0.20-2.25) 0.59 (0.18-1.98) 0 NE NE 0 NE NE 
10 units/week 0.91  (0.74-1.13) 0.90  (0.73-1.11)  0.75  (0.27-2.04) 0.68  (0.23-2.02)    
NE Not estimable, CI confidence interval 
* Adjusted for ethnicity (white/non-white), income, self-rated health (excellent/good/fair/poor), smoking status (4 categories), body mass index (underweight/normal/overweight/obese/severely 
obese/unknown), exercise (self-rated, enough vs. not enough) 
Percent of people in each alcohol consumption category for people who contributed to the above analysis (those who participated in the HALS 2 survey and reported that their alcohol intake during 
the week of the diary was typical). Men (n=1,645): Beer (0 units 43.4%; 1-14 units 30.8%, 15-28 units 12.9%, >28 units 12.7%), Wine (0 units 79.9%, 1-14 units 19.1%, 15-28 units 0.8%, >28 units 
0.2%, n=3), Spirits (0 units 80.7%; 1-14 units 17.4%; 15-28 units 1.4%; >28 units 0.6%, n=9). Women (n=2,378: Beer (0 units 83.3%; 1-14 units 15.4%, 15-28 units 1.1%;  >28 units 0.2%, n=4), 
Wine (0 units 74.1%, 1-14 units 24.7%, 15-28 units 1.1%, >28 units 0.1%, n=3), Spirits (0 units 83.3%; 1-14 units 16.1%; 15-28 units 0.7%; >28 units 0.0%, n=0). 
 
